Chunxia Chen
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 22, 2024
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: May 31, 2023
Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2022
Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 07, 2022
Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 26, 2022
Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 01, 2021
Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3β/IL-8 signaling pathway.
Journal: Acta pharmaceutica Sinica. B
Published: December 04, 2020
CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: September 03, 2020
Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT.
Journal: Cell communication and signaling : CCS
Published: July 31, 2020
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
Journal: Cell communication and signaling : CCS
Published: March 26, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026